H&W in the Media
Aspirin Inventor, Bayer, considers bid for GMO giant, Monsanto
Stocks (^DJI, ^GSPC, ^IXIC) are adding to Wednesday’s losses as crude oil punches through to new highs for the year. Health care (XLV) is leading the way south, while materials (XLB) are still in the green. We’ll have a deep dive on the issues with Stephen Guilfoyle, managing director of Floor Operations for Deep Value Execution Services, live from the New York Stock Exchange.
To discuss the other big stories of the day, Alexis Christoforous is joined by Kevin Mahn, CIO, Hennion & Walsh Asset Management and Scott Rostan, president & founder at Training The Street.
Someone may buy Monsanto
Bayer is considering a bid for Monsanto, but will a possible merger be a pill that’s too big to swallow?
Tiffany & Co. is the latest company to reportedly walk away from an anti-counterfeiting group over Alibaba. But will its departure really help anything?
Instagram’s new look
Instagram is sporting a new logo and interface—and some users aren’t happy about.